A review of Multi-Threat Medical Countermeasures against chemical warfare and terrorism

Military Medicine

Volumn 169, Issue 11, 2004, Pages 850-855

  Cowan, Fred M ^a   Broomfield, Clarence A ^a   Stojiljkovic, Milos P ^b   Smith, William J ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIINFLAMMATORY AGENT; ATROPINE; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYTOKINE RECEPTOR; GLUTAMATE RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 8; MUSTARD GAS; MYCOTOXIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; ORGANOPHOSPHATE; PHOSGENE; PROTEINASE INHIBITOR; SUBSTANCE P; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR; CHEMICAL WARFARE AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTHRAX; BLISTER; BURN; CHEMICAL WARFARE; CIVIL DEFENSE; EBOLA VIRUS; FIBROSIS; HUMAN; HYPOTHESIS; INFLAMMATION; INTOXICATION; MULTI THREAT COUNTERMEASURE; NECROSIS; NONHUMAN; PNEUMONIA; REVIEW; SEPSIS; SEVERE ACUTE RESPIRATORY SYNDROME; SHOCK; SMALLPOX; TERRORISM; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; DRUG DESIGN;

ANTI-INFLAMMATORY AGENTS; BLISTER; CHEMICAL WARFARE; CHEMICAL WARFARE AGENTS; CIVIL DEFENSE; DRUG DESIGN; HUMANS; INFLAMMATION; RESPIRATORY DISTRESS SYNDROME, ADULT; TERRORISM;

EID: 16644391962     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.169.11.850     Document Type: Review

References (70)

1. Fries A, West C: Chemical Warfare. New York, McGraw-Hill, 1921.
2. Jacobs M: War Gases. New York, Interscience Publishing, 1942.
3. Harris R, Paxman J: A Higher Form of Killing: The Secret Story of Gas and Germ Warfare. London, Chatto & Windus, 1982.
4. Gutman WE: Chemical and biological weapons: the silent killers. NBC Def Tech Int 1986; 1: 26-7.
5. Maynard RL, Beswick FW: Organophosphorus compounds as chemical warfare agents. In: Clinical and Experimental Toxicology of Organophosphates and Carbamates. pp 373-85. Edited by Ballantyne B, Marrs TC. Oxford, Butterworth-Heinemann, 1992.
6. Koelle GB: Organophosphate poisoning: an overview. Fundam Appl Toxicol 1981; 1: 129-34.
7. Marshall E: Iraq's chemical warfare: case proved. Science 1984; 224: 130-2.
8. Andersson G: Analysis of two chemical weapons samples from the Iran-Iraq war. NBC Def Technol Int 1986; 1: 62-5.
9. Stojiljkovič MP, Škrbić R, Pavlović N, Romanić S: Nerve gases as means of chemical terrorism in Japan. Arch Toxicol Kinet Xenobiot Metab 1997; 5: 371-83.
10. Tu AT: Anatomy of Aum Shinrikyo's organization and terrorist attacks with chemical and biological weapons. Arch Toxicol Kinet Xenobiot Metab 1999; 7: 45-84.
11. Tu AT: The first mass chemical terrorism using sarin in Matsumoto, Japan. Arch Toxicol Kinet Xenobiot Metab 2001; 9: 65-93.
12. Hay A: At war with chemistry. New Sci 1984; 101: 12-7.
13. Alibek K, Handelman S: Biohazard. New York, NY, Dell Publishing Company, 2000.
14. Cowan FM, Broomfield CA, Lenz, DE, Smith WJ: Putative role of proteolysis and inflammatory response in the toxicity of nerve and blister chemical warfare agents: implications for multi-threat medical countermeasures. J Appl Toxicol 2003; 23: 177-86.
15. Cowan FM, Broomfield CA: Putative roles of inflammation in the dermatopathology of sulfur mustard. Cell Biol Toxicol 1993; 9: 201-13.
16. Cowan FM, Shih T-M, Lenz DE, Madsen JM, Broomfield CA: A hypothesis for synergistic toxicity of organophosphorus poisoning-induced cholinergic crisis and anaphylactoid reactions. J Appl Toxicol 1995; 16: 25-33.
17. Sciuto AM, Stotts RR, Hurt HH: Efficacy of ibuprofen and pentoxifylline in the treatment of phosgene-induced acute lung injury. J Appl Toxicol 1996; 16: 381-4.
18. Sciuto AM, Clapp DL, Hess ZA, Ted S: Moran. The temporal profile of cytokines in the bronchoalveolar lavage fluid in mice exposed to the industrial gas phosgene. Inhal Toxicol 2003; 15: 687-700.
19. Fiori G, Saglini V, Bertini F, Domenighetti G, Mombelli G: Severe poisoning with the organophosphorus insecticide thionazine-2 cases with the development of ARDS (adult respiratory distress syndrome). Schweiz Med Wochenschr 1987; 117: 399-401.
20. Papirmeister B, Gross CL, Meier HL, Petrali JP, Johnson JB: Molecular basis for mustard-induced vesication. Fundam Appl Toxicol 1985; 5: S134-49.
21. Higuchi K, Kajiki A, Nakamura M, Harada S, Pula PJL, Scott AL, et al: Protease released in organ culture by acute inflammatory lesions produced in vivo in rabbit skin by sulfur mustard: hydrolysis of synthetic peptide substrates for trypsin-like and chymotrypsin-like enzymes. Inflammation 1998; 12: 311-34.
22. Arroyo CM, Schafer RJ, Kurt EM, Broomfield CA, Carmichael AJ: Response of normal human keratinocytes to sulfur mustard (HD): cytokine release using a non-enzymatic detachment procedure. Hum Exp Toxicol 1999; 18: 1-11.
23. Sabourin CLK, Casillas RP: Inflammatory gene expression in mouse skin following sulfur mustard exposure. Toxicol Sci 1998; 42: 393.
24. Tsuruta J, Sugisaki K, Dannenberg AM, Jr., Yoshimura T, Abe Y, Mounts P: The cytokines NAP-1 (IL-8), MCP-1, IL-1ā, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation 1996; 20: 293-318.
25. Ricketts KM, Santai CT, France JA, Graziosi AM, Doyel TD, Gazaway MY, et al: Inflammatory cytokine response in sulfur mustard-exposed mouse skin. J Appl Toxicol 2000; Suppl 1: S73-6.
26. McDonough JH, Shih T-M: Neuropharmacological mechanisms of nerve agent induced seizure and neuropathology. Neurosci Biobehav Rev 1997; 21: 559-79.
27. Vanneste Y, Lison D: Biochemical changes associated with muscle fibre necrosis after experimental organophosphate poisoning. Hum Exp Toxicol 1993; 12: 365-70.
28. Doebler J, Shih T-M, Anthony A: Quantitative cytophotometric analyses of mesenteric mast cell granulation in acute soman intoxicated rats. Experimentia 1985; 41: 457-8.
29. Newball HH, Donlon MA, Procell LR, Helegeson EA, Franz DR: Organophosphate-induced histamine release from mast cells. J Pharmacol Exp Ther 1986; 238: 839-45.
30. Gilat E, Cohen G, Chapman S, Raveh L, Rabinowitz I, Manistersky E, et al: Comparative efficacy of antidotal oximes: protection and inflammatory markers following exposure of guinea-pigs to sarin vapor. Proceedings of Bioscience Review 2002. U.S. Army Medical Research and Materiel Command Medical Defense Bioscience Review. Hunt Valley, MD, June 2002.
31. Svensson I, Waara L, Johansson L, Bucht A, Cassel G: Soman-induced interleukin-1ā mRMA and protein in rat brain. Neurotoxicology 2001; 22: 355-62.
32. McLeod CG, Jr.: Pathology of nerve agents: perspectives on medical management. Fundam Appl Toxicol 1985; 6: S10-6.
33. Williams AJ, Berti R, Yao C, Price RA, Velarde LC, Koplovitz I, et al: Central neuro-inflammatory gene response following soman exposure in the rat. Neurosci Lett 2003; 349: 147-50.
34. Eriksson C, Zou LP, Ahlenius S, Winblad B, Schultzberg M: Inhibition of kainic acid induced expression of interleukin-1 ā and interleukin-1 receptor antagonist mRNA in the rat brain by NMDA receptor antagonists. Brain Res Mol Brain 2000; 85: 103-13.
35. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, et al: Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 2000; 97: 11534-9.
36. Smith WJ, Babin MC, Kiser RC, Casillas RP: Development of medical counter-measures to sulfur mustard vesication. Proceedings of the 2000 Medical Defense Bioscience Review, U.S. Army Medical Research Institute of Chemical Defense. Aberdeen Proving Ground, MD, June 2000.
37. Babin MC, Ricketts K, Skvorak JP, Gazaway M, Mitcheltree LW, Casillas RP: Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J Appl Toxicol 2000; S1: S141-4.
38. Casillas RP, Babin MC, Ricketts KM, Castrejon LR, Baker LM, Mann J, Jr., et al: In vivo therapeutic prophylactic protection against cutaneous sulfur mustard injury using the mouse ear vesicant model (MEVM). Proceedings of the 2000 Medical Defense Bioscience Review. U.S. Army Medical Research Institute of Chemical Defense. Aberdeen Proving Ground, MD, June 2000.
39. Mabley JG, Jagtap P, Perretti M, Getting SJ, Salzman AL, Virag L, et al: Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm Res 2001; 50: 561-9.
40. Dal Piaz V, Giovannoni MP, Ciciani G, Becherucci C, Parente L: 4-Substituted-5-acetyl-2-methyl-6-phenyl-3(2H)pyridazinones as PGE2 and IL-1 release inhibitors from mouse adherent macrophages. Pharmacol Res 1994; 4: 367-72.
41. Cowan FM, Broomfield CA, Smith WJ: Suppression of sulfur mustard-increased IL-8 in human keratinocyte cell cultures by serine protease inhibitors: implications for toxicity and medical countermeasures. Cell Biol Toxicol 2002; 18: 175-80.
42. Cowan FM, Broomfield CA, Lenz DE, Shih T-M: Protective action of the serine protease inhibitor N-tosyl-L-lysine chloromethyl ketone (TLCK) against acute soman poisoning. J Appl Toxicol 2001; 21: 293-6.
43. Kotev G: Mechanisms of and experimental therapy for acute soman-induced bronchial spasm. Eksp Med Morfol 1966; 5: 163.
44. Wessler I, Kirkpatrick CJ, Racke K: The cholinergic "pitfall": acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 1999; 26: 198-205.
45. Jacoby DB, Fryer AD: Anticholinergic therapy for airway diseases. Life Sci 2001; 68: 2565-72.
46. Back N, Wilkens H, Steger R: Proteases and protease inhibitors in experimental shock states. Ann NY Acad Sci 1968; 146: 491-509.
47. Lecomte J, Schoffeniels E: Action of 2-PAM and of acetylcholinesterase inhibitors on anaphylactic shock in the rabbit. Biochem Pharmacol 1961; 5: 305-10.
48. Devereaux A, Amundson DE, Parrish JS, Lazarus AA: Vesicants and nerve agents in chemical warfare. Decontamination and treatment strategies for a changed world. Postgrad Med 2002; 112: 90-6.
49. Tanniere-Zeller M, Rochette L, Bralet J: PAF-acether-induced mortality in mice: protection by benzodiazepines. Drugs Exp Clin Res 1989; 15: 553-8.
50. Chen Z-L, Strickland S: Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 1997; 91: 917-25.
51. Cowan FM, Broomfield CA, Smith WJ. Suppression of sulfur mustard-increased IL-8 in human keratinocyte cell cultures by the COX inhibitor indomethacin, the poly(ADP-ribose) polymerase (PARP) inhibitor 3-(4′-bromophenyl)ureidobenzamide and the calmodulin antagonist fluphenazine. Proceedings of Bioscience Review 2002. U.S. Army Medical Research and Materiel Command Medical Defense Bioscience Review. Hunt Valley, MD, June 2002.
52. Cowan FM, Smith WJ, Moran TS, Parris MM, Williams AB, Sciuto AM: Sulfur mustard- and phosgene-increased IL-8 in human small airway cell cultures: implications for medical countermeasures against inhalation toxicity. Joint Service Scientific Conference on Chemical and Biological Defense Research. November 17-20, 2003, Baltimore, MD.
53. Meier HL, Ballough GP, Forster JS, Filbert MG: Benzamide, a poly(ADP-ribose) polymerase inhibitor, is neuroprotective against soman-induced seizure-related brain damage. Ann NY Acad Sci 1999; 890: 330-5.
54. Van Helden HP, Groen B, Moor E, Westerink BH, Bruijnzeel PL: New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release. Drug Chem Toxicol 1998; 21: 171-81.
55. Lau WM, Freeman SE, Szilagyi M: Binding of some organophosphorus compounds at adenosine receptors in guinea pig brain membranes. Neurosci Lett 1988; 94: 125-30.
56. Ribeiro JA: Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators. Eur J Pharmacol 1999; 375: 101-13.
57. Forsythe P, Ennis M: Adenosine, mast cells and asthma. Inflamm Res 1999; 48: 301-7.
58. Bong GW, Rosengren S, Firestein GS: Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-D-aspartate receptors. J Clin Invest 1996; 98: 2779-85.
59. Virag L, Szabo C: Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB J 2001; 15: 99-107.
60. Stojiljkovic MP, Jacevic V, Bokonjic D, Kilibarda V, Bocarov-Stancic A, Milovanovic ZA, et al: Attenuation of general toxic effect of T-2 toxin in rats treated with various formulations of methylprednisolone. Arch Toxicol Kinet Xenobiot Metab 2001; 9: 21-8.
61. Dachir S, Fishbeine E, Meshulam Y, Sahar R, Amir A, Kadar T: Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Hum Exp Toxicol 2002; 4: 197-203.
62. Feuerstein G, Leader P, Siren AL, Braquet P: Protective effect of PAF-acether antagonist, BN 52021, in trichothecene toxicosis. Toxicol Lett 1987; 38: 271-4.
63. Doebler JA, Martin LJ, Morse JD, Ballough GP, Strauss GP, Anthony A: Mesenteric mast cell degranulation in acute T-2 toxin poisoning. Toxicol Lett 1987; 25: 167-74.
64. Yarom R, Bergmann F, Yagen B: Cutaneous injury by topical T-2 toxin: involvement of microvessels and mast cells. Toxicon 1987; 25: 167-74.
65. Fu YT, Lin WG, BaoCheng Z, Quan G: The effect of T-2 toxin on IL-1ā and IL-6 secretion in human fetal chondrocytes. Int Orthop 2001; 25: 199-201.
66. Udobi KF, Childs E, Touijer K: Acute respiratory distress syndrome. Am Fam Physician 2003; 67: 315-22.
67. Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B: Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol 2003; 170: 2797-801.
68. Hanna PC, Acosta D, Collier RJ: On the role of macrophages in anthrax. Proc Natl Acad Sci USA 1993; 90: 10198-201.
69. Luyendyk JP, Shores KC, Ganey PE, Roth RA: Bacterial lipopolysaccharide exposure alters aflatoxin B(1) hepatotoxicity: benchmark dose analysis for markers of liver injury. Toxicol Sci 2002; 68: 220-5.
70. Stone WL, Qui M, Smith M: Lipopolysaccharide enhances the cytotoxicity of 2-chloroethyl ethyl sulfide. BMC Cell Biol 2003; 6: 1.